Increased Incidence of Peripheral Paralysis of the Facial Nerve;Zvýšený výskyt periférnej obrny tvárového nervu

Ceska a Slovenska Neurologie a Neurochirurgie

Volumn 63, Issue 1, 2000, Pages 24-30

  Drobny M ^a,b   Kurca E ^a   Vosko M R ^a  

^a Martinska Fakultna Nemocnica   (Slovakia)

^b Neurologická Klinika ^*  (Slovakia)

Author keywords

Bell's palsy; Borreliosis; Facial nerve palsy; Herpes viruses; Neuritis

Indexed keywords

EID: 0347938611     PISSN: 12107859     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Billue JS. Bell's palsy: an update on idiopathic facial paralysis. Nurse Pract 1997; 22: 97-107.
2. Walling AD. Bell's palsy in pregnancy and the puerperium. J Farm Pract 1993; 36: 559-563.
3. Ikeda M, Hiroshige K, Abiko Y, Onoda K. Impaired specific cellular immunity to the varicella-zoster virus in patients with herpes zoster oticus. J Laryngol Otol 1996; 110: 918-921.
4. Jonsson L, Tien R, Engström M, Thuomas KA. Gd-DPTA enhanced MRI in Bell's palsy and herpes zoster oticus: an overview and implications for future studies. Acta Otolaryngol (Stockh) 1995; 115: 577-584.
5. Morgan M, Moffat M, Ritchie L, Collacott I, Brown T. Is Bell's palsy a reactivation of varicella zoster virus? J Infect 1995; 30: 29-36.
6. Honda H, Takahashi A. Virus-associated demyelination in the pathogenesis of Bell's palsy. Intern Med 1992; 31: 1250-1256.
7. Ikeda M, Kawabata M, Kuga M, Nakazato H. Anti-Borrelia burgdorferi antibodies in patients with facial paralysis. Eur Arch Otorhinolaryngol 1993; 249: 488-491.
8. Morgan M, Nathwani D. Facial palsy and infection: the unfolding story. Clin Infect Dis 1992; 14: 263-271.
9. Moll JW, Markusse HM, Pijnenburg JJ, Vecht CJ, Henzen-Logmans SC. Antineuronal antibodies in patients with neurologic complications of primary Sjögren's sydrome. Neurology 1993; 43: 2574-2581.
10. Savettieri G, Salemi G, Rocca WA, et al. Incidence and lifetime prevalence of Bell's palsy in two Sicilian municipalities. Sicilian Neuro-Epidemiologic Study (SNES) Group. Acta Neurol Scand 1996; 94: 71-75.
11. Womald PJ, Rogers C, Gatehouse C. Speech discrimination in patients with Bell's palsy and a paralysed stapedius muscle. Clin Otolaryngol 1995; 20: 59-62.
12. Brandenburg NA, Annegers JF. Incidence and risk factors for Bell's palsy in Laredo, Texas: 1974-1982. Neuroepidemiology 1993; 12: 313-325.
13. Furuta Y, Takasu T, Sato KC, Fukuda S, Inuyama Y, Nagashima K. Latent herpes simplex virus type 1 in human geniculate ganglia. Acta Neuropathol (Berl) 1992; 84: 39-14.
14. Pechan J. Bellova obrna lícního nervu a její patogenetická léčba. ZN Praha: Avicenum, 1972; 143.
15. Adour KK, Ruboyianes JM, von Doersten PG, et al. Bell's palsy treatment with acydovir and prednisone compared with prednisone alone: a double-blind, randomized, controlled trial. Ann Otol Rhinol Laryngol 1996; 105: 371-378.
16. Bauer CA, Coker NJ. Update on facial nerve disorders. Otolaryngol Clin North Am 1996; 29: 445-454.
17. Jalaludin MA. Methylcobalamin treatment of Bell's palsy. Methods Find Exp Clin Pharmacol 1995; 17: 539-544.
18. Williamson IG, Whelan TR. The clinical problem of Bell's palsy: is treatment with steroids effective? Br J Gen Pract 1996; 46: 743-747.
19. Trembly B. Clinical potential for the use of neuroprotective agents. A brief overview. Ann N Y Acad Sci 1995; 765: 1-20.
20. Cook SP, Macartney KK, Rose CD, Hunt PG, Eppes SC, Reilly JS. Lyme disease and seventh nerve paralysis in children. Am J Otolaryngol 1997; 18: 320-323.
21. Watanabe Y, Aso S, Yasumura S, Kobayashi H, Mizukoshi K. Retro-labyrinthine disorder in cases with peripheral facial palsy. Acta Otolaryngol Suppl (Stockh) 1993; 503: 202-204.